Recordings from Virtual CPNP 2020 are now available for purchase on a by module or bulk purchase. Earn up to 25 hours of APCE credit from a line-up of nationally recognized speakers providing highly relevant content. Don’t miss out on accessing programming that was well received by the 1400 participants.

After purchase, ACPE credit can be earned for up to three years from the session's launch date, and credits will be automatically sent to CPE Monitor upon successful completion of the required examination and evaluation. Take advantage of this great opportunity to advance your learning on your schedule and from the comfort of your home or office! This 25-hour bundle is worth over $875!

Login (or create a FREE account) to purchase the recorded sessions!

Members can access this program for only $545 (for a limited time). Sign in or join now!

Courses

TitleHoursRegister
Biomarker Profiling and Neural Mechanisms for Psychosis ACPE
Dr. Tamminga reports data from the “Bipolar-Schizophrenia Network for Intermediate Phenotypes” (B-SNIP). This was ...[more]

Dr. Tamminga reports data from the “Bipolar-Schizophrenia Network for Intermediate Phenotypes” (B-SNIP). This was started to test conventional psychiatric diagnoses for similarities in biological characteristics using brain imaging, electrophysiological, oculomotor, and cognitive characteristics. From these extensive and complex biomarkers, she found certain biomarkers associated with specific psychiatric disorders. Therefore, her team has re-clustered individuals with psychosis based on biomarkers and found a previously uncorrelated system of biomarkers.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Buprenorphine and Methadone: Navigating Through Transitions of Care ACPE
As the opioid epidemic continues to affect patients and families across the United States, it is imperative health care ...[more]

As the opioid epidemic continues to affect patients and families across the United States, it is imperative health care professionals continue to work towards effective and lasting treatment for patients with opioid use disorder (OUD). Ongoing stigma and lack of education contributes to less than optimal care for those with OUD. Initiating medication assisted treatment (MAT) in an inpatient or emergency department setting and transitioning patients to office-based treatment upon discharge may improve treatment retention.

learn more

1.2
Non-member rate:
$40.00
Member rate: $35.00, login
Burnout of Health Care Providers, Residents, and Students ACPE
Professional burnout is common among health care professionals and may have significant impact on patient care. Identifying and ...[more]

Professional burnout is common among health care professionals and may have significant impact on patient care. Identifying and preventing burnout as well as promoting resilience is important for personal well-being, and for patient safety. Early career clinicians may be more likely to be affected by burnout, so recognition of burnout in students and residents is an important skill for pharmacy educators, including preceptors.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Clinical Pearls 1 ACPE
CPNP members share their experiences dealing with clinical problems. Pearls include an esketamine clinic, pain management and ...[more]

CPNP members share their experiences dealing with clinical problems. Pearls include an esketamine clinic, pain management and buprenorphine, and haloperidol as a non-opioid alternative in the ED.

learn more

1.0
Non-member rate:
$40.00
Member rate: FREE!, login
Clinical Pearls 2 ACPE
CPNP members share their experiences dealing with clinical problems. Pearls include pre-exposure prophylaxis for HIV, bromism, and ...[more]
CPNP members share their experiences dealing with clinical problems. Pearls include pre-exposure prophylaxis for HIV, bromism, and contaminants in CBD products.

learn more

1.0
Non-member rate:
$40.00
Member rate: FREE!, login
Depression / Postpartum Depression: Novel Mechanisms, Formulations, and REMS ACPE
Research suggests that although alterations of central monoamines might contribute to the generation of depressive states, they do ...[more]

Research suggests that although alterations of central monoamines might contribute to the generation of depressive states, they do are not necessarily the primary cause of depression. Treatment resistant depression occurs in at least 15–30% of major depressive disorder cases, and in the post-partum depression population, remission rates remain low. Currently available antidepressants require 4-6 weeks of administration prior to the onset of therapeutic efficacy, during which time patients continue to experience symptoms of depression and suicidal ideation.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
The ECHO Model: Bridging the Gap in Mental Health ACPE
Patients with mental illness are often undertreated, due in part to a lack of resources and access to specialty care for ...[more]

Patients with mental illness are often undertreated, due in part to a lack of resources and access to specialty care for psychiatric concerns. Current evidence supports the use of the ECHO model in managing multiple chronic medical conditions, while the evidence for behavioral health is still preliminary. ECHO programs have been shown to increase primary care provider knowledge, competence, and performance, resulting in improved patient health outcomes on a cost-effective basis.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
E-Cigarettes: An Update on Safety and Effectiveness ACPE
E-cigarette use has been increasing among adults and adolescents since these products were introduced to the United States in 2007. ...[more]

E-cigarette use has been increasing among adults and adolescents since these products were introduced to the United States in 2007. The e-cigarettes market-place has rapidly evolved due to targeted marketing and studies on multiple aspects of e-cigarette use are being published faster than those in health care can assess their importance to clinical practice Given these changes in the products being used and what is known about them, it is important for pharmacists and other health care providers to stay current on emerging data regarding e-cigarettes.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Evaluation and Treatment of Impulsivity and Aggression ACPE
Aggression and agitation is common in inpatient psychiatric settings, and it is important to recognize warning signs early to ...[more]
Aggression and agitation is common in inpatient psychiatric settings, and it is important to recognize warning signs early to prevent rapid escalation to potentially dangerous behaviors. A meta-analysis from 2015 suggests that almost 20% of patients admitted to psychiatric units commit at least one act of violence during their hospitalization. The etiology of aggression is often multifactorial with psychosis, impulsivity, psychopathy, intoxication, cognitive impairment being potential contributing factors.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Forensic Toxicology: What’s New, What’s Old, and Why Dead People Aren’t Like the Living ACPE
Psychiatric and neurologic pharmacists are frequently asked about evaluating toxicological test results. Unfortunately, post-mortem ...[more]

Psychiatric and neurologic pharmacists are frequently asked about evaluating toxicological test results. Unfortunately, post-mortem medication levels do not correlate with those observed in living individuals. This requires additional knowledge about what fluids and/or tissues should be tested based on the suspected substance. This program will provide an overview of the challenges of post-mortem/forensic toxicology, while also reviewing established references, and the challenges of detecting novel psychoactive substances.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Interplay of Sleep, Mental Illness, and Psychotropics ACPE
Difficulties initiating or maintaining sleep is frequently reported by patients in a variety of settings. Sleep disturbances may be ...[more]

Difficulties initiating or maintaining sleep is frequently reported by patients in a variety of settings. Sleep disturbances may be secondary to psychiatric and neurologic disorders and can worsen any underlying mental illness. Several psychiatric medications commonly used to treat mental illness, may have detrimental effects on sleep architecture. This session will review the literature on the impact psychiatric medications have sleep architecture, how to properly assess a patient expressing sleep disturbance, and recommend appropriate treatment.

learn more

0.8
Non-member rate:
$40.00
Member rate: $35.00, login
Long-Acting Injectable Antipsychotics: What to Do When Things Don’t Go As Planned ACPE
Long-acting injectable antipsychotics are commonly prescribed in community and inpatient mental health settings. While there is a ...[more]

Long-acting injectable antipsychotics are commonly prescribed in community and inpatient mental health settings. While there is a great deal of evidence regarding their place in therapy and recommended dosing/administration/monitoring, there is less evidence available that focuses on real world scenarios and what to do after recommended dosing/administration/monitoring has not been followed.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Nerve Growth Factor as a Target for Pain Management ACPE
This session will review the role of nerve growth factor in the pathogenesis of different types of pain and how it interacts with ...[more]

This session will review the role of nerve growth factor in the pathogenesis of different types of pain and how it interacts with other modulators in the transmission of pain. It will cover the history and future of development of nerve growth factor modulators and the challenges that have emerged with these therapies. This session will also outline the potential benefits and risks of nerve growth factor inhibitors for application to patient care.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Pain, Opioids and Suicide ACPE
In the US, deaths due to suicide and unintentional overdose are on the rise and pose an urgent public health concern. In 2017, over ...[more]

In the US, deaths due to suicide and unintentional overdose are on the rise and pose an urgent public health concern. In 2017, over 40% of suicide and overdose deaths, so-called “Deaths of Despair”, were due to opioids. This represents a 2-1/2 fold increase from 17% in 2000.1 Pain alters neurocircuitry and increases the risk of suicide, which may be unknown to many psychiatric pharmacists. There are several key shared risk factors and prevention approaches that should be known by psychiatric pharmacists.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Psychedelic Use in Psychiatric Disorders ACPE
Mood, anxiety, and substance-use disorders are among the most prevalent mental illnesses in the population. While several ...[more]

Mood, anxiety, and substance-use disorders are among the most prevalent mental illnesses in the population. While several pharmacological treatments are available, not all patients are successfully treated with these agents. Recent studies suggest that psychedelic agents including psilocybin, lysergic acid diethylamide (LSD), ketamine, and 3,4-methylenedioxy-methamphetamine (MDMA) may be helpful adjunctive treatments for depression, anxiety, and substance use disorders.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Psychiatric and Behavioral Adverse Effects and Complications of Antiseizure Medications ACPE
Antiseizure medications are commonly used to treat a variety of neurological (e.g. epilepsy, epilepsy syndromes, pain, spasticity, ...[more]
Antiseizure medications are commonly used to treat a variety of neurological (e.g. epilepsy, epilepsy syndromes, pain, spasticity, migraine headache) and psychiatric conditions (bipolar disorder, aggression, personality disorders). It is well established that antiseizure medication use can be associated with positive or negative psychiatric medication effect(s) depending on the individual medication and patient factors. Patients with epilepsy may also already have a pre-existing psychiatric or neurologic disorder that may be exacerbated by the use of an antiseizure medication.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Psychiatric and Neurologic Medication Pipeline ACPE
As medication management experts, pharmacists must remain up-to-date by understanding newly marketed medications and those in the ...[more]

As medication management experts, pharmacists must remain up-to-date by understanding newly marketed medications and those in the clinical development pipeline. To fulfill this role, pharmacists must master essential clinically relevant knowledge about each new medication’s efficacy for the tested indication, tolerability, and safety. This information includes the pharmacodynamic mechanism of action, pharmacokinetics, drug interactions, and pharmacoeconomics.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Secondary Psychosis: Differential Diagnosis of a First Episode ACPE
Several clinical conditions and substances can produce symptoms of psychosis that mimic the clinical presentation of schizophrenia ...[more]

Several clinical conditions and substances can produce symptoms of psychosis that mimic the clinical presentation of schizophrenia and other mental illnesses. There is ongoing debate in the medical literature about a “standard” medical work-up for patients presenting with first-episode psychosis (FEP). Extensive medical work-up can be potentially expensive and traumatic for the patient, especially for children presenting with psychosis.

learn more

1.2
Non-member rate:
$40.00
Member rate: $35.00, login
Substance Use Disorders in Adolescents ACPE
Many individuals begin to misuse substances in adolescence and young adulthood The presence of substance use disorders in ...[more]

Many individuals begin to misuse substances in adolescence and young adulthood The presence of substance use disorders in adolescents has been linked to a number of negative outcomes, including death. The treatment of substance use disorders in adolescents must be appropriately tailored to meet the needs of the patient’s developmental stage, cognitive ability, and influence from family, friends, and community and should be multimodal in approach.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Suicide Prevention Strategies ACPE
Suicide is the 10th leading cause of death in the United States resulting in more than 47,000 deaths in 2017, or about one death ...[more]

Suicide is the 10th leading cause of death in the United States resulting in more than 47,000 deaths in 2017, or about one death every 11 minutes. Suicide rates vary by race/ethnicity, age, and other population characteristics, and there are more than 120 prescription drugs with labeling that includes language about suicidal ideation or behavior. There is a great need for widespread education about suicide awareness and prevention and for health care entities to adopt a collaborative approach to the problem.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Treatment of HIV-Associated Neurocognitive Disorder ACPE
According to the Centers for Disease Control and Prevention, 1,008,929 individuals in the United States (U.S.) were identified as ...[more]
According to the Centers for Disease Control and Prevention, 1,008,929 individuals in the United States (U.S.) were identified as living with HIV in 2016 with 38,739 new cases of HIV diagnosed in the U.S. in 2017.1 In this population, HIV-associated neurocognitive disorder (HAND) is estimated to occur in approximately 50% of adults with HIV, which can cause cognitive slowing, difficulty concentrating, and impairment of memory.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Update on Stimulant Dosage Forms for ADHD ACPE
Attention deficit/hyperactivity disorder (ADHD) is one of the more common psychiatric diagnoses within the pediatric population. ...[more]

Attention deficit/hyperactivity disorder (ADHD) is one of the more common psychiatric diagnoses within the pediatric population. While rates may decline with age, a large percentage of these individuals will continue to meet criteria for diagnosis in adulthood.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Update on the Evidence-based Treatment of Bipolar Depression ACPE
Bipolar I disorder occurs in approximately 1% of the population, with approximately 3-4% suffering from bipolar-spectrum disorders. ...[more]

Bipolar I disorder occurs in approximately 1% of the population, with approximately 3-4% suffering from bipolar-spectrum disorders. The predominant polarity and reason for disability in bipolar disorder is bipolar depression. The identification, differentiation from unipolar depression and management of bipolar depression is complicated. In particular, “bimodal” mood stabilizers that are equally effective for mania and depression are rare and antidepressants run the risk of activation of induction of mania.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Updates and Advances in Antipsychotic Induced Metabolic Adverse Events ACPE
The most recent guidelines for the monitoring and treatment of patients with antipsychotic-related metabolic side effects were ...[more]

The most recent guidelines for the monitoring and treatment of patients with antipsychotic-related metabolic side effects were published in 2005 Since then, there have been many changes to metabolic disorder treatments and new antipsychotics have become available. While the disease states comprising metabolic disorder may each have relevant guidelines, it is important to understand how to treat these issues in the context of mental illness. Health care providers should also be aware of the risks of metabolic syndrome associated with various antipsychotic medications.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login
Violence and Mental Illness ACPE
As reports of increasingly frequent mass-casualty shootings in America fill the news, calls to “fix the mental health ...[more]

As reports of increasingly frequent mass-casualty shootings in America fill the news, calls to “fix the mental health system” collide in the public square with proposals to expand and enforce restrictive gun laws. In this lecture, Professor Jeffrey Swanson will describe the contours of violence in America from a public health perspective, placing our country’s problem in context with international comparisons.

learn more

1.0
Non-member rate:
$40.00
Member rate: $35.00, login